Free Trial
NYSE:ANTX

(ANTX) (ANTX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.01
$1.05
50-Day Range
N/A
52-Week Range
$47.02
$64.78
Volume
429,336 shs
Average Volume
1.48 million shs
Market Capitalization
$30.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

(ANTX) MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
96.1% Upside
$2.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$3.81 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.94) to ($1.53) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.19 out of 5 stars

Medical Sector

492nd out of 910 stocks

Pharmaceutical Preparations Industry

231st out of 426 stocks

ANTX stock logo

About (ANTX) Stock (NYSE:ANTX)

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

ANTX Stock News Headlines

ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q2 2024
Why Is AN2 Therapeutics (ANTX) Stock Down 35% Today?
Say Goodbye to the US Dollar
The warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late...
ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q4 2023
Say Goodbye to the US Dollar
The warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late...
AN2 Therapeutics just downgraded at Evercore ISI, here's why
AN2 Therapeutics just downgraded at Leerink, here's why
See More Headlines
Receive ANTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ANTX) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/13/2024
Today
9/07/2024
Next Earnings (Estimated)
11/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Previous Symbol
NASDAQ:ANTX
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.00
High Stock Price Target
$3.00
Low Stock Price Target
$1.00
Potential Upside/Downside
+96.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Net Income
$-64,730,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$3.30 per share

Miscellaneous

Free Float
23,628,000
Market Cap
$30.44 million
Optionable
Not Optionable
Beta
-0.11
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Joseph R. Swedish (Age 66)
    Exec. Chairman
  • Ms. Gail Koziara Boudreaux (Age 57)
    Pres, CEO & Director
  • Mr. John Edward Gallina (Age 58)
    Exec. VP & CFO
  • Ms. Gloria Marie McCarthy (Age 65)
    Exec. VP and Chief Admin. & Transformation Officer
  • Mr. Peter David Haytaian (Age 48)
    Exec. VP & Pres of Commercial and Specialty Bus. Division

ANTX Stock Analysis - Frequently Asked Questions

How were (ANTX)'s earnings last quarter?

(ANTX) (NYSE:ANTX) released its quarterly earnings data on Tuesday, August, 13th. The company reported ($0.48) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.59) by $0.11.

When did (ANTX) IPO?

(ANTX) (ANTX) raised $69 million in an initial public offering (IPO) on Friday, March 25th 2022. The company issued 4,600,000 shares at a price of $14.00-$16.00 per share.

What other stocks do shareholders of (ANTX) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that (ANTX) investors own include Intel (INTC), CrowdStrike (CRWD), DocuSign (DOCU), Micron Technology (MU), Valero Energy (VLO), Pfizer (PFE) and Align Technology (ALGN).

This page (NYSE:ANTX) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners